Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Aug;32(4):303-7.
doi: 10.1016/j.joa.2015.09.006. Epub 2015 Nov 4.

Incidence of cardiac implantable electronic device infections and migrations in Japan: Results from a 129 institute survey

Affiliations

Incidence of cardiac implantable electronic device infections and migrations in Japan: Results from a 129 institute survey

Hiroshi Nakajima et al. J Arrhythm. 2016 Aug.

Abstract

Background: We conducted a survey of the infection burden associated with the implantation of cardiac implantable electronic devices (CIEDs) in Japan.

Methods: The institutes were selected using annual device implantation data provided by Medtronic Japan Co., Ltd. The data sampling period was from January 1 to December 31, 2013. Institutes were classified into Group P, at which only pacemakers were implanted, and Group A, at which other CIEDs were implanted. Group P was further classified into three sub-groups by implantation number. The infection rate was compared between groups using logistic regression analysis.

Results: A total of 129 of 138 institutes responded. The annual infection rate was 1.12% for overall CIEDs. The institute at which 15-29 pacemakers were implanted had a high infection rate (2.11%). No statistically significant difference was observed (adjusted p=0.1131). The overall migration rate was 0.50%. Complete removal of the CIED system was performed in 55.8% of patients who underwent implantation.

Conclusions: This survey was the first on CIED infection and migration in Japan. The CIED infection rate (1.12%) was similar to that previously reported. A high infection rate (2.77%) was observed in the infection experienced institutes.

Keywords: Cardiac implantable electronic device; Implantable cardioverter defibrillator; Infection; Lead extraction; Migration.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Comparison of the Group P subgroups with Group A. Group P was classified into three sub-groups based on the number of implantations. Group P1 included the institutes in which less than 14 devices per year were implanted. Institutes at which 15–29 implantations were performed were classified as Group P2. The institutes at which more than 30 implantations were performed were classified as Group P3. The infection rate of Group P2 was 2.11%, and it was higher than that of the other groups and the infection rate in the US in 1996 ; dotted line. The infection rate in Group P2 was compared with that of the other groups using logistic regression analysis. The results of the analysis showed the inferiority of Group P2 to Group P3 with respect to the infection rate. However, no statistically significant difference was observed after Bonferroni correction.
Fig. 2
Fig. 2
Treatment of infection: Comparison of Group P with A. 50% of infections in Group P and 63% in Group A were treated with complete removal of the CIED system. There was no statistically significant difference between groups in the total removal rate. Overall complete removal rate was 56%.

References

    1. Kurtz S.M., Ochoa J.A., Lau E. Implantation trends and patient profiles for pacemakers and implantable cardioverter defibrillators in the United States: 1993–2006. Pacing Clin Electrophysiol. 2010;33:705–711. - PubMed
    1. Mond H.G., Irwin M., Ector H. The world survey of cardiac pacing and cardioverter defibrillators: calendar year 2005: an International Cardiac Pacing and Electrophysiology Society (ICPES) project. Pacing Clin Electrophysiol. 2008;31:1202–1212. - PubMed
    1. Uslan D.Z., Tleyjeh I.M., Baddour L.M. Temporal trends in permanent pacemaker implantation: a population study. Am Heart J. 2008;155:896–903. - PMC - PubMed
    1. Greenspon A.J., Patel J.D., Lau E. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States: 1993 to 2008. J Am Coll Cardiol. 2011;58:1001–1006. - PubMed
    1. Baddour L.M., Epstein A.E., Erickson C.C. American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee; Council on Cardiovascular Disease in Young; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Nursing; Council on Clinical Cardiology; Interdisciplinary Council on Quality of Care; American. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation. 2010;121:458–477. - PubMed

LinkOut - more resources